NCT00414401

Brief Summary

Although beta-blockers are known to prolong survival for patients with reduced left ventricular ejection fraction, their use in the community and the VA is suboptimal.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status
completed
Estimated enrollment
1,500 participants
Study completion date

June 2006

Actual (reported)
Listed locations
1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

  1. Study Start

    May 2001

    Date type not reported

    This date has not been verified as actual or estimated.

  2. Study Completion

    June 2006

    Actual (reported)

  3. First Submitted

    December 19, 2006

    Actual (reported)

  4. First Posted

    December 21, 2006

    Actual (reported)
Last Updated
April 7, 2015
Status Verified
December 2006
Last Update Submitted
April 6, 2015

Conditions

Heart Failure, Congestive

Outcome Measures

Primary Outcomes (1)

  • Prescription for any beta-blocker

Secondary Outcomes (1)

  • Prescription for carvedilol or metoprolol succinate

Study Arms (1)

Arm 1

OTHER
Behavioral: Clinical Reminder

Interventions

Clinical ReminderBEHAVIORAL
Arm 1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Those undergoing echocardiography at one of the participating laboratories with an ejection fraction \< 45%.

You may not qualify if:

  • aortic stenosis, mitral stenosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Palo Alto Health Care System, Palo Alto, CA

Palo Alto, California, 94304-1290, United States

Location

Related Publications (2)

  • Heidenreich PA, Gholami P, Sahay A, Massie B, Goldstein MK. Clinical reminders attached to echocardiography reports of patients with reduced left ventricular ejection fraction increase use of beta-blockers: a randomized trial. Circulation. 2007 Jun 5;115(22):2829-34. doi: 10.1161/CIRCULATIONAHA.106.684753. Epub 2007 May 21.

    PMID: 17515459RESULT

  • Heidenreich PA, Chacko M, Goldstein MK, Atwood JE. ACE inhibitor reminders attached to echocardiography reports of patients with reduced left ventricular ejection fraction. Am J Med. 2005 Sep;118(9):1034-7. doi: 10.1016/j.amjmed.2004.12.028. No abstract available.

    PMID: 16164891RESULT

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Paul A. Heidenreich, MD MS

    VA Palo Alto Health Care System, Palo Alto, CA

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 19, 2006

First Posted

December 21, 2006

Study Start

May 2001

Date type not reported

This date has not been verified as actual or estimated.

Study Completion

June 2006

Actual (reported)

Last Updated

April 7, 2015

Record last verified: 2006-12

Locations

US(1)